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Abstract Introduction In the modern era of frameless
stereotaxis (FL), the role of frame-based (FB) stereotactic
needle biopsy is evolving. Methods Retrospective review of
prospective database of 106 lesions in 91 consecutive
patients undergoing FB stereotactic needle biopsy with a
systematic ‘‘geologic core’’ technique by a single surgeon.
Diagnostic accuracy was calculated comparing biopsy
diagnosis with final pathology in 11 patients who underwent
subsequent surgical resection. All instances of intra-opera-
tive bleeding through the needle were prospectively noted
and compared with post-biopsy CT scan. Lesions were
classified as risky for FL technique if they were (1) infra-
tentorial or pineal, (2) within 10 mm of the circle of Willis
or root of the Sylvian fissure, or (3) within 10 mm of deep
cerebral veins. Results Diagnostic yield was 94%. Diag-
nostic accuracy was 91%. Of 18 lesions involving the
corpus callosum, 13 (72.2%) were GBM 2 were anaplastic
astrocytoma, and 1 each were found to be anaplastic
oligodendroglioma, primary central nervous system lym-
phoma (PCNSL) and tumescent MS. Of 25 multifocal
lesions, malignant primary brain tumor was diagnosed in 17
(68%) (11 GBM, 3 PCNSL, 2 anaplastic ologodendrogli-
oma, and 1 anaplastic astrocytoma). Mortality was 0%.
Three patients developed temporary neurologic deficits and
one had permanent deficit. Absence of persistent blood
through the biopsy needle had a negative predicative value
of 98.8% for subsequent neuroimaging blood [5 mm
diameter. According to our criteria, 80% of patients would
have been candidates for FL biopsy. Conclusions
Stereotactic biopsy is an effective, safe and important
technique for histologic diagnosis of brain lesions, partic-
ularly for multifocal and corpus callosum lesions. Post-
biopsy CT can be safely reserved for patients who demon-
strate persistent bleeding through the biopsy needle. FB
stereotaxy remains an important technique for the 20% with
small or deep seated lesions or when it is advantageous to
avoid an incision, a burr hole or general anesthesia.
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Introduction
Frame-based stereotaxis (FB) is a well-established tech-
nique for performing three-dimensional point stereotactic
needle procedures such as diagnostic biopsies, lesion
aspirations, and brachytherapy instillation. It has proved a
safe and effective tool since it was first coupled with
computed planar imaging nearly three decades ago [1–7].
Despite its history, questions still persist regarding FB,
including quantifying the risk of non-diagnosis or sampling
error for tumor biopsy, and the actual need for post biopsy
neuroimaging. Its popularity has also been limited by
patient transport logistical issues as well as general neu-
rosurgeons’ relative unfamiliarity or discomfort with
frame-based equipment and the calculations involved with
defining stereotactic entry points, trajectories and targets.
The development of frameless stereotaxis (FL) has been
rapidly embraced by most neurosurgeons to the extent that
it is rapidly supplanting FB techniques in general neuro-
surgical practice. Some early reports have suggested that FL
techniques are as good or better than the traditional frame-
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based approach [8, 9]. Recent large series seem to indicate
similar diagnostic yields and complication rates, but have
failed to agree upon factors such as differences in cost and
operating room time between the two methods [10, 11].
This suggests surgeon and institution experience and pref-
erence as major contributing factors and makes clear the
necessity of continued investigation and reporting of clini-
cal experience with these techniques. The percentage of
potential cases that can safely and effectively approached
using FL versus FB technique, the relative desirability and
risk of local versus general anesthesia as well as the need for
open burr hole versus twist drill are all areas for ongoing
debate. Thus the relative role of both FB and FL in modern
neurosurgical practice warrants further study.
Methods
In the 44 month period from December 12, 1998 through
September 2, 2003 (four years, eight months) 106 brain
lesions in 91 patients underwent 95 consecutive FB cere-
bral needle biopsy procedures by a single surgeon (MEL)
at one university neurosurgical service consisting of a
university hospital, a free-standing specialty pediatric
hospital, and a Veteran’s Administration (VA) hospital. All
patients were entered into, and followed on a prospective
clinical outcomes database. Patients with multifocal solid
lesions only underwent stereotactic biopsy if they did not
have a history of primary-histology-proven malignancy
within the previous two years, and then only if systemic
work-up with chest-, abdomen- and pelvis-computed
tomography (CT), as well as nuclear medicine bone scan
failed to reveal systemic disease that could be safely
biopsied in lieu of one of the cerebral lesions.
Surgical technique
Biopsy technique included both the Cosman-Roberts-Wells
(CRW) stereotactic system (Integra, Plainsboro, NJ) and the
Leksell Model G stereotactic system (Elekta, Inc, Norcross,
GA). Targeting imaging included both magnetic resonance
(MR) and computed tomography (CT), with CT technique
predominantly utilized at the VA hospital where MR tar-
geting was unavailable. Entry techniques included burr hole
as well as twist drill craniostomy. Entry locations were
determined by lesion location and size. Most procedures
were performed in awake patients unless age, lesion location,
or mental status required general endotracheal anesthesia.
Stereotactic instruments included the Nashold side-cutting
biopsy needle (Integra, Plainsboro, NJ), 10 mm and 3 mm
Sedan side-cutting biopsy needles (Elekta, Inc, Norcross,
GA), and the Backlund aspiration needle system (Elekta, Inc,
Norcross, GA). Biopsy technique was routinely planned to
systematically sample tissue at both the edge of the lesion as
well as the center of the lesion along the planned needle
trajectory in a ‘‘geological core sample’’ manner at different
depths, with multiple samples obtained at each depth by
orienting the needle side opening in different radial direc-
tions (Fig. 1). All patients underwent immediate post-
procedure CT imaging to assess the biopsy sight, were
observed for 12 h in either an intensive care (2:1 nursing
ratio) or a neuro-step-down critical care unit (3:1 nursing
ratio), and most were routinely discharged home after one
overnight hospital stay.
Outcomes assessment
Pathology diagnostic accuracy was assessed by success at
arriving at a histological diagnosis (all lesions), as well as
confirmation of the needle biopsy result after surgical
resection of the lesion in those patients who underwent
subsequent open craniotomy. Complications were assessed
both clinically and by immediate post-biopsy CT imaging.
All instances of bleeding through the needle(s) during the
procedure were noted prospectively and characterized as:
none, quickly clearing with 1–2 needle irrigations, or per-
sisting beyond two needle irrigations. All new neurological
deficits were noted as well as whether they were temporary,
permanent, and/or required additional surgical interven-
tion. Bleeding at the biopsy site on CT imaging was
Fig. 1 Left Schematic
representation of the ‘‘Geologic
Core’’ biopsy technique
illustrating multiple biopsy
depths (white lines) along a
single needle trajectory. Right
T2 weighted coronal MRI with
biopsy plan. Multiple sample
sites throughout the
heterogeneous mass are
indicated at 0, 1, and 2
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assessed and classified as B5 mm in diameter or[5 mm in
diameter, as well as whether or not it led to new neuro-
logical symptoms and/or required additional surgical
intervention. The relationship of intra-operative findings of
bleeding at the time of biopsy were correlated with the
post-biopsy CT image findings by calculating the positive
and negative predictive values for subsequent blood on CT
scan using standard techniques [12].
Assessment of candidacy for frameless stereotactic
alternative
All lesions were objectively measured on hard copy neu-
roimages with calipers, or on computer monitor screens
with objective measurement tools, according to published
techniques [13]. The anatomic location of each lesion as
well as the distance relationship between the margin of the
lesion and the arteries of the circle of Willis, the root of the
Sylvian fissure, and the deep cerebral venous system
(intracerebral veins and vein of galen), were noted, mea-
sured and recorded. In the portion of the study dedicated to
determining the percentage of cases in this series that could
definitely have been performed using a frameless stereo-
tactic (FL) technique we assumed an average accuracy with
of FL of ±2–4 mm. Lesions were excluded from FL
technique consideration for safety concerns if they were (1)
infratentorial or located in the pineal region, (2) located
within 10 mm of an artery of the circle of Willis or the root
of the Sylvian fissure, or (3) located within 10 mm of the
deep cerebral venous system. Remaining lesions in the
series were then divided into those C5 mm in diameter and
those C10 mm in diameter for probability assessment for
consistently hitting the target and obtaining the diagnosis
assuming a central lesion target and average targeting error
of 2 mm and 4 mm, respectively.
Results
Median patient age was 55.5 years with a range from
3–81 years (Mean, 50 years; SD 21.7). There were 47 men
and 44 women. Four patients had single lesions sampled on
two different occasions separated by significant time. Four
had two lesions, and one had eight lesions, addressed during
the same procedure. One hundred lesions were approached
for diagnostic biopsy, four were simple therapeutic cyst
aspirations, and two were for installation of P32 for intra-
cystic brachytherapy for craniopharyngioma. A summary of
the technical aspects of the series is presented in Table 1
and the lesion locations and needle approached utilized are
summarized in Table 2. For the diagnostic biopsy cases, the
median number of separate samples submitted to pathology
for each lesion was four (range, 2–16).
Diagnostic yield and accuracy
Of the 100 consecutive diagnostic biopsies performed, a
definite histological and/or microbiology diagnosis was
obtained in 94 (94% diagnostic yield). Of the six
Table 1 Techniques utilized for 106 consecutive lesions
Stereotactic system
Cosman–Roberts–Wells (CRW) 68 64%
Leksell model G 38 36%
Targeting imaging
Magnetic resonance imaging (MR) 95 90%
Computed tomography (CT) 11 10%
Anesthesia (95 procedures)
Local anesthesia with intravenous sedation 68 71.6%
General endotracheal 27 28.4%
Altered mental status 14 –
Pediatric (ages 3–13) 8 –
Posterior fossa sitting position 3 –
Language barrier 1 –
Patient choice 1 –
Entry technique
Twist drill craniostomy 91 86%
Open burr hole 15 14%
Posterior fossa sitting position 3 –
Brain stem lesion 3 –
Pineal region 2 –
Leksell temporal ring approach 2 –
Converted from twist drill 1 –
Other 4 –
Table 2 Lesion locations and approaches
Lesion location
Single lobar 33 (31.1%)
Multi-focal 25 (23.6%)
Bi-hemispheric via corpus callosum 18 (17.0%)
Multi-lobar (contiguous, uni-hemispheric) 7 (6.6%)
Diencephalic 12 (11.3%)
Brain stem 8 (7.5%)
Midbrain 3 –
Midbrain and pons 2 –
Pons 2 –
Pons and medulla 1 –
Pineal region 3 (2.8%)
Approaches
Perpendicular to convexity directly over lesion 51 –
Standard coronal suture entry 50 –
Posterior fossa––middle cerebellar peduncle 3 –
Forehead 2 –
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inconclusive cases, three demonstrated only necrosis on
needle biopsy and we went on to confirm Glioblastoma
multiforme (GBM) at subsequent surgery (two repeat
needle biopsies, one open craniotomy). Two were sug-
gestive but not definitive for bacterial abscess and
responded to empiric antibiotic treatment. One was shown
to be tumescent multiple sclerosis (MS) on subsequent
open biopsy. The diagnoses obtained are outlined in
Table 3.
Eleven of the 94 diagnostic biopsy patients where we
obtained a definite histological or microbiology diagnosis
on needle biopsy subsequently underwent open craniotomy
within two months of the original biopsy. Review of these
pathology results against those obtained with the stereo-
tactic needle biopsy revealed that the larger sampling size
of the open craniotomy confirmed the original stereotactic
needle biopsy result in ten of eleven cases (90.9% accu-
racy). The only outlier was a single patient thought to have
a low grade Oligodendroglioma on stereotactic needle
biopsy who subsequently was confirmed to have a higher
grade tumor (anaplastic oligodendroglioma).
Corpus callosum and multifocal lesions
Of the eighteen lesions involving the corpus callosum, 13
(72.2%) turned out to be GBM, but two were found to be
anaplastic astrocytoma, and one each were found to be
anaplastic oligodendroglioma, primary central nervous
system lymphoma (PCNSL) and tumescent MS, respec-
tively. Altogether, 27.8% of these cases turned out not to
have GBM. Of the 25 multifocal lesions in our series, only
one turned out to have abscesses and only three had met-
astatic brain tumors (two of the three with no known
primary). While radiation necrosis was the diagnosis for 2
(8%), a malignant primary brain tumor was the cause of the
multifocal lesions in 17 (68%) (11 GBM, three PCNSL,
two anaplastic ologodendroglioma, and one anaplastic
astrocytoma).
Complications and predictive value of intra-operative
findings
Intraoperative bleeding from the twist drill craniostomy
puncture only required conversion to open burr hole in one
instance (1/92 = 1.1%). In this instance, a bleeding surface
vessel branch was identified and cauterized. Post-biopsy
CT images did not reveal a single instance of entry site
hemorrhage in the other 91 instances. The incidence of
identifying any intraparenchymal blood at the biopsy site
on post-biopsy CT images is outlined in Table 4 and
examples are presented in Fig. 2.
Some amount of blood was identified in the needle or
the specimen during the procedure in 23 cases. Continued
bleeding that required persistence of the needle at the
biopsy site and irrigation and clearing of the needle until
bleeding spontaneously ceased was present in 19 instances
(19%). There were no cases where the bleeding through the
needle did not eventually stop with continuing irrigation.
For the subsequent finding of any blood at all at the biopsy
site on post-biopsy CT, the presence of persistent bleeding
beyond two needle irrigations intraoperatively has a posi-
tive predictive value of 63.2% and a negative predictive
value of 86.4%. For the subsequent finding of [5 mm of
blood at the biopsy site on post-biopsy CT, the presence of
this finding intraoperatively has a positive predictive value
of only 21.1%, but a very powerful negative predictive
value of 98.8%. Thus if there is no persistent bleeding
beyond two needle irrigations intraoperatively, there is
only a 1.2% chance of identifying blood [5 mm diameter
on post-biopsy neuroimaging.
Table 3 Diagnoses in 100 consecutive needle biopsies
WHO Grade IV Astrocytoma 26
WHO Grade III Astrocytoma 5
WHO Grade II Astrocytomaa 8




Central nervous system lymphoma 4










Progresssive multifocal leukoencephalopathy 1
Viral encephalitis 1
Inconclusive 6
WHO World Health Organization
a Three of the eight grade II tumors were gemistocytic astrocytomas
Table 4 Post-needle biopsy CT scan findings and significance in 100
consecutive cases
No hemorrhage noted on CT 83 (83%)
Small B5 mm area of hemorrhage 18 (18%)
[5 mm area of hemorrhage 5 (5%)
New temporary neurological deficit 3 (3%)
New permanent neurological deficit 1 (1%)
Additional surgery due to hemorrhage 0 (0%)
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Clinically, only three patients developed new temporary
neurological symptoms or signs and only one developed
permanent new neurological symptoms or signs (Table 4).
The temporary clinical complications included headache in
one (pineal region tumor), new partial hemiparesis in one
and new temporary double vision in a patient with a mid-
brain lesion. The permanent complication was permanent
diplopia and subtle worsening of pre-existing hemiparesis
in a patient with a midbrain malignant glioma. No patient
required operation for cerebrospinal fluid diversion or for
hematoma evacuation as a result of stereotactic biopsy.
Clinical complication risk was higher for patients with
brain stem lesions (12.5% temporary and another 12.5%
mild permanent) and pineal region lesions (33.3%
temporary, 0% permanent) versus patients with non-brain
stem or pineal region lesions (1.1% temporary and 0% new
permanent).
Proportion of cases that would have been candidates
for frameless stereotactic technique
Of our 100 consecutive diagnostic biopsy cases, eleven
arose in the midbrain, pons or pineal region, and seven
were located within 10 mm of an artery of the circle of
Willis or the root of the Sylvian fissure, or within 10 mm of
the deep cerebral venous system (see Figs. 3, 4 and 5 for
examples). In a paradigm where a lesion had to satisfy
these anatomic location constraints as well as be at least
Fig. 2 Examples of post-biopsy
hemorrhage (arrows). Left A
small (\5 mm), clinically silent
hemorrhage adjacent to post-
biopsy air within the left frontal
subcortical white matter. Right
A larger hemorrhage within the
deep white matter in a patient
with temporary worsening of
her left hemiparesis following
biopsy
Fig. 3 a Axial targeting MR
(T1-weighted with gadolinium
contrast) in an adult with a non-
enhancing anaplastic
astrocytoma of the whole pons.
Note that the CRW frame is
rotated to provide direct access
to a left middle cerebellar
peduncle needle trajectory
without interfering with the left
posterior frame post. b Post-
biopsy non-contrast CT scan
demonstrating the open burr
whole entry point (arrow) as
well as the 2 cm core biopsy site
(between asterisks)
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5 mm in size for eligibility, 82% of the 100 lesions in our
series would have been candidates for FL needle biopsy as
an alternative to the FB technique. No lesion would be
excluded for size concerns. In a paradigm where a lesion
had to satisfy these anatomic location constraints as well as
be at least 10 mm in size for targeting likelihood, 80% of
the 100 lesions in our series would have been candidates
for FL needle biopsy as an alternative to the frame-based
technique. Four lesions would have been excluded for size
and targeting accuracy concerns (two of which were
already excluded for anatomic location concerns. All
together, based on these assumptions 80–82% of the
lesions in our series would have been candidates for FL
needle biopsy as an alternative to the FB technique.
Discussion
The reliability of frame-based stereotactic biopsy
Overall, our data support the notion that stereotactic
biopsy is an effective means of establishing tissue diag-
nosis for intracranial lesions. Our diagnostic yield of 94%
compared favorably with recent and historical large series
reporting ranges of 90–98% (Table 5). Even for the 6%
of our cases with nondiagnostic results, tissue pathology
was still suggestive enough to effectively guide treatment
in all but one instance. In our series, lesion size and/or
location did not correlate with diagnostic yield or
accuracy.
Fig. 4 a Axial targeting MR (T1-weighted with gadolinium contrast)
in an adult with an enhancing pineal region mass showing the left
forehead twist drill craniostomy needle trajectory and the planned
2 cm core biopsy site using a Leksell G frame. b Sagittal targeting
MR (T1-weighted with gadolinium contrast) again demonstrating the
forehead twist drill craniostomy needle trajectory and the planned
2 cm core biopsy site, but also demonstrating how close the target is
to the internal cerebral vein, the vain of Galen and the straight sinus.
c Post-biopsy non-contrast CT scan with air defects at the biopsy site.
The lesion is intrinsically mildly hyperdense throughout and no
bleeding resulted from the biopsy
Fig. 5 a Axial targeting MR (T1-weighted with gadolinium contrast)
using a Leksell G frame in an adult with what turned out to be medial
temporal lobe encephalitis demonstrating abnormal enhancement
within 1 cm of the circle of Willis arteries. b Axial FLAIR-weighted
targeting MR demonstrating a larger area of lesion signal change as
well as the deep target point. c Post-biopsy non-contrast CT scan with
air defect indicating the 2 cm core biopsy tract without any post-
biopsy bleeding
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Diagnostic accuracy is an equally important consider-
ation in evaluating the utility of stereotactic biopsy, though
it is reported far less frequently in the literature than
diagnostic yield. At least one study has suggested that
biopsy specimens cannot provide a sufficient accuracy of
diagnosis to reliably guide treatment of brain neoplasms,
citing discrepancies as high as 38–49% when biopsies
specimens were compared with final pathological diagnosis
obtained at open surgical resection [14]. Those figures,
however, were based upon biopsies performed by multiple
outside facilities and few details regarding the specific
techniques used are provided. Large single center series
with higher individual procedure volumes are likely more
representative of the true potential of stereotactic biopsy,
and a thorough and systematic biopsy technique is neces-
sary for optimal results. Our accuracy rate of 90.9% is in
keeping with that of Grunert et al. [15], who reported a
diagnostic accuracy of 91% in 47 patients who underwent a
subsequent open resection. Woodworth et al. [16] reported
an accuracy rate of 76%, though results correctly guided
treatment in 91% of their series of 21 patients who
underwent open biopsy. Our single inaccuracy was a WHO
II oligodendroglioma which was subsequently found to be
WHO III at the time of resection. While we did not detect
this tendency, a few reports have suggested that mixed
gliomas with a significant oligodendroglial component may
be more commonly mis-graded on stereotactic biopsy than
other glioma histologies [14, 16].
The specific method of tissue biopsy likely plays a key
role in determining diagnostic accuracy and yield. Past
series appear to be relatively evenly divided between the
use of biopsy forceps [1, 4] or a side-cutting biopsy needle
[17, 18] while many report using both [15, 19, 20], and still
other surgeons still use needle aspiration techniques or the
Backlund spiral devise (Elekta, Inc, Norcross, GA). More
recent series tend to favor a side-cutting needle exclusively
[10, 11, 18], which has the advantage of preserving a core
of intact cross-sectional tissue architecture which facilitates
histological interpretation. The present series used a rela-
tively aggressive biopsy technique which we feel
minimizes sampling error and increases the likelihood of
an accurate diagnosis. When practical, a target point
beyond the edge of the lesion was selected. Multiple sec-
tions were then taken with the side-cutting needle at serial
depths along the track. In this manner a ‘‘geologic core’’
could be obtained with a single needle trajectory, providing
samples of normal brain, lesion edge, and central contents.
The utility of this approach is reflected in the accurate
Table 5 Summary of large stereotactic series












302 [90 NR 2.3 3
Edner [2] Karolinska 1981 Leksell 345 91 if ct
used
? \1 2.3
Lobato [3] Madrid 1982 Leksell 100 97 NR 7 0
Apuzzo [5] USC 1983 BRW 83 94 NR 4 0
Lunsford[6] Pittsburgh 1984 Leksell 102 96.5 NR 3 0
Mundinger [7] Friedburg 1985 Mundinger 815 3 0.6
Apuzzo [4] USC 1987 BRW 500 95.6 ? 1 0.2
Bernstein [20] Toronto 1986–1994 BRW 300 NR NR 6.3 1.7
Grunert [15] JGU 1994 BRW/CRW 200 92 91 3 1




1996 15centers: Talairach 8
Leksell 2 both
2 other 3
370 94 97.7 0.8 sig.
7 transient
1.3
Ulm,Friedman [17], Gainesville 2001 200 98.5 2 0
Field, Kondziolka[18] Pittsburgh 2001 Leksell 500 NR NR 1.28% radiographic
hemorrhage
0.2
Smith,McDermot [10] UCSF 2006 CRW or BRW 213a 90 NR 2 0
Woodworth et al. [11] Johns-Hopkins 2006 Leksell or CRW 160a 91 NR 13 1
Linskey (present) U. Arkansas 2007 CRW or Leksell 106 96 91 4 0
NR Not reported, BRW Brown–Roberts–Wells, CRW Cosman–Roberts–Wells
a Frame-based arm only
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grading of all but one of the gliomas in our series, and in
the low number (three) of necrosis-only results in our GBM
biopsies.
Role of stereotactic biopsy in clinical decision making
One particularly important role for stereotactic biopsy is
confirming tissue diagnosis for patients with multiple brain
lesions, specifically in the setting of a negative systemic
metastatic survey. Of our 25 multifocal lesions, a signifi-
cant majority (68%) were primary CNS neoplasms,
reinforcing the importance of tissue diagnosis when no
obvious metastatic source can be found. Not all patients
with multiple CNS brain lesions can be assumed to have
metastatic disease. Even higher instances of multifocal
primary CNS disease have been reported elsewhere.
Yamada et al. [21] found zero metastases out of 25 mul-
tifocal brain lesions that were referred for stereotactic
biopsy. All three patients with multifocal lesions described
in Lunsford et al. [6] were found to have gliomas. In all,
Lunsford also found that nearly 10% of pre-procedure
diagnoses classified as ‘‘secure’’ were overturned after
biopsy. Another nine out of 44 patients with a ‘‘strongly
suspected’’ pre-op diagnosis were found to have a pathol-
ogy that was not considered in the pre-biopsy differential.
A retrospective review by Arbit and Galicich [22] similarly
found that results of stereotactic biopsy dictated different
treatment than radiographic diagnosis in 19% of cases.
Our data also indicate that stereotactic biopsy is an
important tool for establishing the diagnosis of corpus
callosum lesions. Conventional teaching has often been
that patients with lesions crossing the corpus callosum do
not have resectable lesions and can be assumed to have
GBM, and thus can be empirically treated. While most of
the 18 patients in our series with a callosal lesion did turn
out to have GBM, 27.8% had lesions which mandated
different management, including oligodendroglioma,
PCNSL, and tumescent MS. This finding becomes partic-
ularly important given that some authors have questioned
the utility of biopsy in the management of gliomas [14]. In
that study, only three out of 81 lesions were located in the
corpus callosum. The present data indicate that a diagnosis
of glioma based solely upon characteristic imaging is
premature without a tissue diagnosis.
Safety considerations in stereotactic biopsy
It is of interest that the morbidity rates reported in recent
stereotactic series differ little from those performed nearly
three decades ago (Table 5). Mortality rates, in contrast,
have tended to decline slightly over the same period, possibly
through technological and infrastructure improvements
which allow for faster recognition and correction of post-
procedural emergencies. Our morbidity rate of 4% (tempo-
rary or permanent neurologic deficit) corroborates the results
of these other large series and also demonstrates that an
aggressive sampling technique can be employed without
compromising patient safety. This is consistent with the
study of Mcgirt et al. [23], which found that increasing the
number of biopsy samples did not independently impact
morbidity if the samples were collected along a single needle
trajectory.
Brainstem and pineal locations accounted for three of
four complications, and this is consistent with the findings
of previous authors who correlated morbidity with pineal
[18] and deep-seated lesions [23]. In general, relatively
small numbers of pineal locations in this and other series
make generalization to an accurate risk profile for these
lesions difficult. A contrary view was offered by Regis
et al. [19], who reported the results of a multicenter series
of 370 pineal region stereotactic biopsies and found that
complication rates were no higher than in other locations
if only permanent deficits were considered. That study
did note an increased likelihood of complication associ-
ated with ‘‘hard’’ tumors (pineocytomas, teratomas, and
astrocytomas) and recommends proceeding with a micro-
surgical approach in the event that tissue is not easily
obtained with the first pass of the biopsy needle.
In seeking possible predictors of post-procedure com-
plication, we have specifically identified the finding of
blood within the biopsy needle that persists beyond two
needle irrigations. Shastri-Hurst et al. [24] have previously
noted the finding of blood intra-operatively in 7/203 cases
as having a positive predictive value of 57% for post-
operative deterioration but a sensitivity of only 30%. In our
series, 19% of patients met our particular criteria for per-
sistent intra-operative bleeding. We found the absence of
this finding in the remaining 81% to have a very high
(98.6%) negative predicative value for a significant
([5 mm) hemorrhage being identified on the post-opera-
tive CT. Our analysis of the Shastri-Hurst et al. data
reveals a similar negative predicative value (95.4%) for
post-procedural deterioration. With such high negative
predicative values, routine post-biopsy neuroimaging in the
absence of bleeding through the needle persisting beyond
two irrigations or development of a new neurological
deficit can probably be safely eliminated from stereotactic
needle biopsy patient care protocols.
While some authors have suggested that patients with
normal postoperative scans do not require further assess-
ment [25], Field et al. [18] found a small but non-zero
incidence (0.4%) of delayed neurologic deterioration after
uncomplicated brain biopsy with negative post-operative
imaging. This leaves the question of an appropriate level of
nursing care for these patients still open to debate. It is our
opinion that a step-down level facility or well trained
146 J Neurooncol (2009) 93:139–149
123
neurosurgical floor capable of providing neurologic
assessments every 2 h is sufficient for the initial 12 post-
operative hours in uncomplicated cases. In other publica-
tions, poor glycemic control in diabetics [23] and platelet
counts \150,000 [18] have also been identified as statisti-
cally significant independent risk factors for poor outcome
after stereotactic biopsy and should be considered in post-
biopsy management decisions. .
Frameless stereotaxy: a hypothetical cohort
Given the increasing popularity of frameless neuro-navi-
gation systems in stereotactic biopsy, we sought to
establish criteria through which we could determine the
suitability of frameless stereotaxis (FL) for patients in our
series. We began with the assumption that frame-based
stereotaxis (FB) represents the gold standard for targeting
accuracy and examined the literature for assessments of FB
and FL systems.
In reviewing the spatial accuracy of various FB and FL
systems, it is important to understand the practical signif-
icance of the different measures of accuracy commonly
cited. Intraoperative computer workstations provide an
estimate of root mean square error (RMS) following co-
registration of skin fiducials or the stereotactic headframe.
However this value should not be considered indicative of
true accuracy. Rather, RMS represents the degree of
internal consistency between data points––in this case the
computed coordinates within the virtual space of the
computer workstation. RMS gives no information regard-
ing the correspondence of those coordinates to the actual
location of objects in physical space. This concept was
elegantly demonstrated by Mascott et al. who found no
statistically significant correlation of RMS values with the
accuracy of marker placement in a large in vivo study [26].
Studies using phantom models typically measure the mean
error of localization, which represents the average magni-
tude of the distance between the probe and its intended
target. This should not be confused with the mean errors
reported for individual axes in some in vivo [27] and
phantom [28] studies which utilized planar imaging to
measure targeting accuracy. In such instances mean errors
refers to the average error within a single anatomic plane.
A Euclidean error is then calculated as the square root of
the sum of the squares of the mean errors in each dimen-
sion. Euclidean error is therefore generally larger than
mean error, and more representative of the actual distance
from a target one could reliably expect to achieve.
FB has traditionally been touted as being capable of sub-
millimeter accuracy, though recent studies suggest that this
may not be an entirely realistic expectation. Hall et al. [29]
found a euclidean error of 1.53 mm using a Leksell frame
and MRI imaging in a phantom model. In a large phantom
model study, Maciunas et al. [30] found that while the
mean mechanical errors of the CRW and BRW frames
were less than 1 mm, at a 99.9% confidence interval they
can only be expected to achieve a mechanical accuracy of
2 mm or less. When factors such as imaging, point selec-
tion, and vector calculations were all considered, the
‘‘application error’’ at the 99.9% confidence interval
increased to 3.1–5.0 mm for four different frame systems.
It is perhaps not practical, though, to make estimates of
accuracy based upon an extreme limit of error that is likely
to occur once in 1,000 cases. For this same series, the mean
error of localization, or average distance between the probe
and its intended target, was between 1.2 and 1.9 mm for
the various systems tested. We feel that this is a more
realistic estimate of the sort of accuracy one can expect in a
given procedure. This corresponds well with in vivo
assessments of FB for deep brain stimulator targeting
accuracy, which found average stereotactic errors of 1.4–
2 mm [31].
There are several factors which likely contribute to the
inherently higher accuracy of FB. These systems have their
frame of reference rigidly fixed to the skull and established
as soon as the frame is applied. Fiducial markers applied to
skin are inherently more mobile and must be re-referenced
to the navigation system once the patient is positioned,
introducing two potential sources of error. Errors of
imprecise trackable probe positioning as well as computer
cursor positioning can be reduced, but not eliminated. The
location of the fiducials has a significant impact on the zone
of maximal correlation which increases accuracy and thus
accuracy can vary considerably through various locations
in a given registered target volume. The use of anatomic
surface landmark registration in lieu of fiducial placement
has consistently demonstrated lower accuracy rates [32],
particularly for posterior lesions where reliable anatomic
landmarks are fewer.
In vivo assessments of FL systems have tended to yield
larger error measurements than FB. Dorward et al. [27]
found a euclidean error of 4.8 mm in the in vivo arm of their
study. Mascott et al. [26] report mean localization errors
between 3.3 and 5.4 mm. One relatively recent comparative
phantom study actually found a smaller euclidean error in a
frameless system when a specific planning and targeting
protocol was used (probe’s eye) [28]. It must be noted, as
those authors themselves attest, that skull phantom models
tend to overestimate the accuracy of FL systems, since such
models simulate placing the fiducials directly upon the skull
rather than the overlying skin, eliminating one major source
of error in skin fiducial based systems. Indeed, in the
Mascott study, mean localization error fell to 1.4–1.9 mm
when skull impanted fiducials were used. Continued
investigation in this realm is important as advances in
computer image processing and algorithms enable
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neuronavigational systems to gain ground on the relatively
established frame-based technologies. However, the above
investigations indicate that currently, while it may be
unrealistic to assume submillimetric accuracy for FB sys-
tems, it is probably reasonable to expect reliable targeting
within 1–1.5 mm. Applying similar standards to FL systems
using skin fiducials, that expected error rises to 3–4 mm and
occasionally even greater depending on registration
technique.
With this in mind, we devised our criteria of potential
candidacy for FL biopsy. We found that fully 80% of our
patients were candidates for frameless approach. Depending
on which estimates of accuracy are used, FL systems can be
expected to reliably target lesions of [5–10 mm. Grunert
et al. [33] came to a more conservative conclusion and
suggested that lesions less than 15 mm should be reserved
for FB approach. From a practical standpoint, requiring a
lesion diameter of at least 10 mm rather than 5 mm
excluded only two patients from the FL eligible group.
While based on accuracy considerations alone,[80% of
biopsies could be accomplished through FL techniques,
there are less easily quantifiable variables which ultimately
influence technique selection. The risks of general anes-
thesia need to be considered, and the FB technique has
traditionally been accomplished with local anesthesia and
sedation. However in at least two comparative series, the
surgeons induced general anesthesia in all patients [8, 11].
This clearly influenced the outcome measure of total time
and cost, which both studies found to favor FL. A com-
parative series conducted by Smith et al. [10] which used
local anesthetic for the FB arm found a substantial reduc-
tion in operating room time and cost with FB. While we
utilized general anesthesia in 28.4% of cases, the remainder
were done under local anesthesia. Frame-based stereotaxis
has also typically been considered less invasive as it can
usually be performed through a tiny stab incision and twist-
drill craniostomy. While the FL technique could theoreti-
cally be performed through a twist drill craniostomy, rather
than a burr hole, most FL technique series report the use of
burr holes. Regardless, the three-point skull screw fixation,
locking-ball-socket, device usually used for FL technique
requires an actual incision to expose enough skull surface
to seat the device and cannot be inserted through a simple
stab wound. While 14% of our cases did require an incision
and an open burr hole, this more invasive approach was
safely avoided in the remaining 86%. Given the similarity
of more objective measures such as diagnostic yield and
complication rate between the two techniques [10, 11],
such discrepancies serve to highlight the important role
individual surgeon training, preference and experience
have in determining technique selection. For diagnosis of
small deep-seated lesions, familiarity with frame-based
techniques remains an important tool.
Conclusions
Frame-based stereotaxis through a systematic ‘‘core-sam-
pling’’ technique is a safe, reliable and valuable tool for
obtaining tissue diagnosis and directing future therapy.
Stereotactic biopsy is particularly valuable in the evalua-
tion of patients with multiple brain lesions in the absence of
a known metastatic source, and for lesions involving the
corpus callosum. The absence of persistent blood in the
biopsy needle at the time of surgery has a high negative
predicative value for the presence of hemorrhage on post-
operative CT imaging. Post-operative CT scanning can
probably be safely reserved for those patients who dem-
onstrate persistent bleeding through the needle after several
irrigation clearing attempts or develop new neurological
deficits. Frame-based stereotaxis remains the gold-standard
for targeting accuracy, though in practice [80% of lesions
can be safely and effectively approached through frameless
biopsy with neuro-navigation systems. Frame-based tech-
nique is indicated for approaching brainstem, pineal, and
deep peri-vascular lesions. For larger and more superficial
lesions, less easily quantifiable considerations such as
surgeon preference and institution specific protocols and
infrastructure are more immediately important determi-
nants. Given the current state of the art, Frame-based
stereotaxis remains an important technique, though one of
fading prominence in the evolving frameless era.
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